Modular Medical, Inc. (MODD)
USD 0.89
(-8.75%)
USD 0.89
(-8.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.27 Million USD | 4.74% |
| 2023 | 2.16 Million USD | 114.85% |
| 2022 | 1 Million USD | -71.34% |
| 2021 | 3.52 Million USD | 259.48% |
| 2020 | 980.12 Thousand USD | 447.78% |
| 2019 | 178.92 Thousand USD | 1056.54% |
| 2018 | 15.47 Thousand USD | -79.21% |
| 2017 | 74.42 Thousand USD | -61.59% |
| 2016 | 193.76 Thousand USD | 17.3% |
| 2015 | 165.17 Thousand USD | 25.43% |
| 2014 | 131.68 Thousand USD | 20.93% |
| 2013 | 108.89 Thousand USD | 23.6% |
| 2012 | 88.1 Thousand USD | 24.77% |
| 2011 | 70.6 Thousand USD | 14.93% |
| 2010 | 61.43 Thousand USD | 14.26% |
| 2009 | 53.76 Thousand USD | 21.19% |
| 2008 | 44.36 Thousand USD | 17.84% |
| 2007 | 37.65 Thousand USD | 20.8% |
| 2006 | 31.16 Thousand USD | 31.17% |
| 2005 | 23.76 Thousand USD | 115.05% |
| 2004 | 11.05 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 2.27 Million USD | 4.74% |
| 2024 Q3 | 2.35 Million USD | 10.99% |
| 2024 Q1 | 2.11 Million USD | -2.73% |
| 2024 Q2 | 2.12 Million USD | 0.52% |
| 2024 Q4 | 2.27 Million USD | -3.48% |
| 2023 FY | 2.16 Million USD | 114.85% |
| 2023 Q2 | 695.11 Thousand USD | -29.85% |
| 2023 Q1 | 990.91 Thousand USD | -1.86% |
| 2023 Q4 | 2.16 Million USD | 203.27% |
| 2023 Q3 | 715.29 Thousand USD | 2.9% |
| 2022 Q4 | 1 Million USD | -88.78% |
| 2022 FY | 1 Million USD | -71.34% |
| 2022 Q3 | 8.99 Million USD | 38.96% |
| 2022 Q2 | 6.47 Million USD | 15.15% |
| 2022 Q1 | 5.62 Million USD | 59.62% |
| 2021 Q2 | 1.29 Million USD | -4.48% |
| 2021 FY | 3.52 Million USD | 259.48% |
| 2021 Q4 | 3.52 Million USD | 172.64% |
| 2021 Q3 | 1.29 Million USD | 0.03% |
| 2021 Q1 | 1.35 Million USD | 37.99% |
| 2020 Q4 | 980.12 Thousand USD | 256.79% |
| 2020 FY | 980.12 Thousand USD | 447.78% |
| 2020 Q1 | 253.47 Thousand USD | 41.66% |
| 2020 Q2 | 330.59 Thousand USD | 30.42% |
| 2020 Q3 | 274.7 Thousand USD | -16.9% |
| 2019 Q2 | 46.83 Thousand USD | 181.15% |
| 2019 Q3 | 62.93 Thousand USD | 34.36% |
| 2019 FY | 178.92 Thousand USD | 1056.54% |
| 2019 Q4 | 178.92 Thousand USD | 184.32% |
| 2019 Q1 | 16.65 Thousand USD | 7.68% |
| 2018 Q2 | 21.4 Thousand USD | -71.24% |
| 2018 FY | 15.47 Thousand USD | -79.21% |
| 2018 Q1 | 74.42 Thousand USD | -66.2% |
| 2018 Q3 | 32.6 Thousand USD | 52.31% |
| 2018 Q4 | 15.47 Thousand USD | -52.54% |
| 2017 FY | 74.42 Thousand USD | -61.59% |
| 2017 Q4 | 220.18 Thousand USD | 3.53% |
| 2017 Q3 | 212.67 Thousand USD | 3.77% |
| 2017 Q2 | 204.94 Thousand USD | 5.77% |
| 2017 Q1 | 193.76 Thousand USD | 3.46% |
| 2016 FY | 193.76 Thousand USD | 17.3% |
| 2016 Q4 | 187.28 Thousand USD | 3.72% |
| 2016 Q2 | 174.33 Thousand USD | 5.54% |
| 2016 Q3 | 180.56 Thousand USD | 3.57% |
| 2016 Q1 | 165.17 Thousand USD | 3.62% |
| 2015 Q2 | 139.54 Thousand USD | 5.97% |
| 2015 FY | 165.17 Thousand USD | 25.43% |
| 2015 Q1 | 131.68 Thousand USD | 3.89% |
| 2015 Q4 | 159.4 Thousand USD | 3.97% |
| 2015 Q3 | 153.32 Thousand USD | 9.88% |
| 2014 Q4 | 126.76 Thousand USD | 4.28% |
| 2014 Q1 | 108.89 Thousand USD | 4.51% |
| 2014 Q2 | 116.1 Thousand USD | 6.62% |
| 2014 FY | 131.68 Thousand USD | 20.93% |
| 2014 Q3 | 121.55 Thousand USD | 4.7% |
| 2013 Q4 | 104.19 Thousand USD | 4.57% |
| 2013 FY | 108.89 Thousand USD | 23.6% |
| 2013 Q3 | 99.63 Thousand USD | 4.78% |
| 2013 Q2 | 95.09 Thousand USD | 7.94% |
| 2013 Q1 | 88.1 Thousand USD | 4.23% |
| 2012 FY | 88.1 Thousand USD | 24.77% |
| 2012 Q4 | 84.52 Thousand USD | 4.89% |
| 2012 Q3 | 80.58 Thousand USD | 5.0% |
| 2012 Q2 | 76.74 Thousand USD | 8.69% |
| 2012 Q1 | 70.6 Thousand USD | 2.99% |
| 2011 Q2 | 65.35 Thousand USD | 6.38% |
| 2011 FY | 70.6 Thousand USD | 14.93% |
| 2011 Q4 | 68.56 Thousand USD | 2.54% |
| 2011 Q3 | 66.86 Thousand USD | 2.31% |
| 2011 Q1 | 61.43 Thousand USD | 1.4% |
| 2010 Q2 | 57.9 Thousand USD | 7.69% |
| 2010 Q1 | 53.76 Thousand USD | 1.08% |
| 2010 Q4 | 60.58 Thousand USD | 2.9% |
| 2010 Q3 | 58.87 Thousand USD | 1.68% |
| 2010 FY | 61.43 Thousand USD | 14.26% |
| 2009 Q1 | 44.36 Thousand USD | 2.32% |
| 2009 FY | 53.76 Thousand USD | 21.19% |
| 2009 Q4 | 53.19 Thousand USD | 2.31% |
| 2009 Q2 | 50.72 Thousand USD | 14.32% |
| 2009 Q3 | 51.99 Thousand USD | 2.5% |
| 2008 Q4 | 43.36 Thousand USD | 2.02% |
| 2008 Q3 | 42.5 Thousand USD | 2.26% |
| 2008 Q2 | 41.56 Thousand USD | 10.39% |
| 2008 Q1 | 37.65 Thousand USD | -0.15% |
| 2008 FY | 44.36 Thousand USD | 17.84% |
| 2007 Q4 | 37.7 Thousand USD | 3.23% |
| 2007 FY | 37.65 Thousand USD | 20.8% |
| 2007 Q3 | 36.52 Thousand USD | 5.16% |
| 2007 Q2 | 34.73 Thousand USD | 11.44% |
| 2007 Q1 | 31.16 Thousand USD | 3.06% |
| 2006 FY | 31.16 Thousand USD | 31.17% |
| 2006 Q4 | 30.24 Thousand USD | 5.47% |
| 2006 Q3 | 28.67 Thousand USD | 5.19% |
| 2006 Q1 | 23.76 Thousand USD | 17.71% |
| 2006 Q2 | 27.25 Thousand USD | 14.71% |
| 2005 Q3 | 18.41 Thousand USD | 32.77% |
| 2005 Q4 | 20.18 Thousand USD | 9.65% |
| 2005 Q2 | 13.86 Thousand USD | 0.0% |
| 2005 FY | 23.76 Thousand USD | 115.05% |
| 2004 FY | 11.05 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 95.567% |
| BrainsWay Ltd. | 15.31 Million USD | 85.164% |
| Cerus Corporation | 144.3 Million USD | 98.426% |
| Envoy Medical, Inc. | 9.4 Million USD | 75.835% |
| electroCore, Inc. | 8.94 Million USD | 74.6% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 57.469% |
| IceCure Medical Ltd | 4.24 Million USD | 46.503% |
| Inogen, Inc. | 121.38 Million USD | 98.128% |
| OrthoPediatrics Corp. | 72.56 Million USD | 96.869% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 92.319% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 28.597% |
| MaxCyte, Inc. | 36.1 Million USD | 93.708% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -22.95% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -434.235% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.304% |
| PAVmed Inc | 57.13 Million USD | 96.024% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 91.077% |
| RxSight, Inc. | 22.18 Million USD | 89.76% |
| Sight Sciences, Inc. | 46.43 Million USD | 95.107% |
| SI-BONE, Inc. | 61.05 Million USD | 96.278% |
| TELA Bio, Inc. | 59.16 Million USD | 96.16% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 98.006% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 77.982% |
| Acutus Medical, Inc. | 54.83 Million USD | 95.857% |
| Talis Biomedical Corporation | 29.22 Million USD | 92.226% |
| Spectral AI, Inc. | 12.4 Million USD | 81.679% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 90.179% |
| CVRx, Inc. | 39.28 Million USD | 94.216% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 81.0% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 6.475% |
| Bioventus Inc. | 589.79 Million USD | 99.615% |
| Venus Concept Inc. | 107.1 Million USD | 97.879% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 95.602% |
| LivaNova PLC | 1.15 Billion USD | 99.803% |
| 908 Devices Inc. | 37.49 Million USD | 93.94% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.677% |
| Nemaura Medical Inc. | 26.37 Million USD | 91.387% |
| NeuroPace, Inc. | 86.99 Million USD | 97.388% |
| LENSAR, Inc. | 22.4 Million USD | 89.861% |
| Apyx Medical Corporation | 52.31 Million USD | 95.657% |
| Cutera, Inc. | 518.12 Million USD | 99.561% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 92.253% |
| BioSig Technologies, Inc. | 4.68 Million USD | 51.505% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 96.107% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 89.427% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.896% |
| Axonics, Inc. | 82.35 Million USD | 97.241% |
| Outset Medical, Inc. | 190.91 Million USD | 98.81% |
| IRIDEX Corporation | 24.91 Million USD | 90.881% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.167% |
| IRadimed Corporation | 20.73 Million USD | 89.043% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -35.723% |
| INVO Bioscience, Inc. | 19.99 Million USD | 88.637% |
| Telesis Bio, Inc. | 40.87 Million USD | 94.441% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 94.43% |
| Varex Imaging Corporation | 668.6 Million USD | 99.66% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.333% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 36.394% |
| Pulmonx Corporation | 60.63 Million USD | 96.253% |
| Dynatronics Corporation | 11.78 Million USD | 80.713% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 44.094% |
| Semler Scientific, Inc. | 6.27 Million USD | 63.764% |
| InMode Ltd. | 75.91 Million USD | 97.007% |
| Bruker Corporation | 2.83 Billion USD | 99.92% |
| Cytosorbents Corporation | 29.98 Million USD | 92.423% |
| DexCom, Inc. | 4.19 Billion USD | 99.946% |
| Align Technology, Inc. | 2.45 Billion USD | 99.907% |
| Viveve Medical, Inc. | 10.84 Million USD | 79.054% |
| ZimVie Inc. | 795.85 Million USD | 99.715% |
| Movano Inc. | 5.97 Million USD | 61.956% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 97.828% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -434.235% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 81.0% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.644% |
| Profound Medical Corp. | 12.66 Million USD | 82.062% |
| Insulet Corporation | 1.85 Billion USD | 99.878% |
| enVVeno Medical Corporation | 2.43 Million USD | 6.694% |
| Surmodics, Inc. | 65.82 Million USD | 96.548% |
| iCAD, Inc. | 8 Million USD | 71.604% |
| Nuwellis, Inc. | 6.78 Million USD | 66.49% |
| Biotricity, Inc. | 35.91 Million USD | 93.675% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.981% |
| Aethlon Medical, Inc. | 2.47 Million USD | 8.374% |
| InspireMD, Inc. | 8.14 Million USD | 72.095% |
| PAVmed Inc. | 57.13 Million USD | 96.024% |
| BIOLASE, Inc. | 35.34 Million USD | 93.572% |
| Beyond Air, Inc. | 29.77 Million USD | 92.369% |
| FONAR Corporation | 57.45 Million USD | 96.046% |
| AxoGen, Inc. | 101.16 Million USD | 97.754% |
| Vivani Medical, Inc. | 25.03 Million USD | 90.925% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.412% |
| Inari Medical, Inc. | 209.32 Million USD | 98.915% |
| UFP Technologies, Inc. | 118.04 Million USD | 98.075% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 82.097% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -3.943% |
| Tenon Medical, Inc. | 5.56 Million USD | 59.188% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -27.712% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 87.116% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.928% |
| Sintx Technologies, Inc. | 6.59 Million USD | 65.539% |
| NanoVibronix, Inc. | 2.68 Million USD | 15.413% |
| Quanterix Corporation | 78.08 Million USD | 97.09% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 36.394% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 53.49% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.783% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.601% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 86.381% |
| NeuroMetrix, Inc. | 1.33 Million USD | -70.427% |
| Hyperfine, Inc. | 9.8 Million USD | 76.816% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.092% |
| Biomerica, Inc. | 2.66 Million USD | 14.683% |
| Bone Biologics Corporation | 831.4 Thousand USD | -173.273% |
| AVITA Medical, Inc. | 19.86 Million USD | 88.563% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -15.115% |
| Silk Road Medical, Inc | 114.15 Million USD | 98.01% |